Efanesoctocog Alfa Prophylaxis in Patients with Hemophilia A with Synovial Hypertrophy

Trial Identifier: LPS18168
Sponsor: Sanofi
Start Date: September 2025
Primary Completion Date: October 2027
Study Completion Date: October 2027
Condition: Hemophilia

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
CANADA, Ontario HAMILTON, Ontario, CANADA, L8N 3Z5
Japan Saitama, Japan, 330-8777
JAPAN, Hiroshima HIROSHIMA, Hiroshima, JAPAN, 734-8551
JAPAN, Kanagawa KAWASAKI, Kanagawa, JAPAN, 216-8511
JAPAN, Tokyo TOKYO, Tokyo, JAPAN, 160-0023
TAIWAN, PROVINCE OF CHINA Kaohsiung City, TAIWAN, PROVINCE OF CHINA, 80756
TAIWAN, PROVINCE OF CHINA TAICHUNG, TAIWAN, PROVINCE OF CHINA, 407
TAIWAN, PROVINCE OF CHINA Taipei, TAIWAN, PROVINCE OF CHINA, 114
United States, Indiana Indianapolis, Indiana, United States, 46260
UNITED STATES, California Los Angeles, California, UNITED STATES, 90007
UNITED STATES, Iowa IOWA CITY, Iowa, UNITED STATES, 52242
UNITED STATES, Ohio Columbus, Ohio, UNITED STATES, 43203-1779